Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium

Corabotase is the first investigational molecule in a newly designated class of recombinant neuroinhibitors, RNITM, as recognized by the WHO and USAN Phase II data in glabellar (frown) lines to be featured as a late-breaking presentation at the SCALE Symposium A broad Phase II and Phase III clinical program is advancing corabotase across multiple aesthetic and therapeutic indications Corabotase... The post Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium appeared first on Montreal Gazette .

Original source: Montreal Gazette